A
Apex Research Foundation | Jackson, TN
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
MK-1242
Vericiguat
Ziltivekimab
Olpasiran
Maridebart Cafraglutide
Tirzepatide
MK-1242-035
LY3298176
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...
Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab
This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF...
Enrolling
Heart Failure With Preserved Ejection Fraction
Obesity
Drug: Placebo
Drug: Maridebart cafraglutide
The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...
Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems